Influence of exercise training on leptin levels in patients with stable coronary artery disease: A pilot study by Kosydar-Piechna, Magdalena et al.
477www.cardiologyjournal.org
ORIGINAL ARTICLE
Cardiology Journal
2010, Vol. 17, No. 5, pp. 477–481
Copyright © 2010 Via Medica
ISSN 1897–5593
Address for correspondence:  Magdalena Kosydar-Piechna, MD, Department of Cardiac Rehabilitation and Noninvasive
Electrocardiology, Institute of Cardiology, Alpejska 42, 04–628 Warszawa, Poland, tel: +48 22 343 44 08, fax: +48 22 343 45 19,
e-mail: mkosydar@ikard.pl
Received: 5.11.2009 Accepted: 12.03.2010
Influence of exercise training on
leptin levels in patients with stable
coronary artery disease: A pilot study
Magdalena Kosydar-Piechna1, Maria Bilińska1, Jadwiga Janas2, Ryszard Piotrowicz1
1Department of Cardiac Rehabilitation and Noninvasive Electrocardiology,
Institute of Cardiology, Warsaw, Poland
2Department of Clinical Biochemistry, Institute of Cardiology, Warsaw, Poland
Abstract
Background: This study was designed to examine the influence of exercise training on leptin
levels in patients with stable coronary artery disease (CAD).
Methods: Sixty-four male patients, mean age 55.6 ± 6.0 years, were randomized either to six
weeks of aerobic training, three times a week, at 60–80% of maximal heart rate (training
group, Ex, n = 32) or to a control group (n = 32). Exercise stress test was performed and body
mass index (BMI), waist-to-hip ratio (WHR), waist circumference and plasma leptin levels
were measured at the beginning and end of the study.
Results: Physical capacity increased significantly only in Ex patients (max workload in
METs from 7.7 ± 1.4 to 8.2 ± 1.4, p < 0.05). There were no significant differences between
initial and final results in either group in terms of BMI, WHR or waist circumference.
Although, at the end of the study, leptin levels did not change in Ex patients (6.7 ± 3.2 vs
6.9 ± 3.6 ng/mL, NS), they did increase significantly in the control group (8.0 ± 4.0 vs 9.3 ±
± 5.2 ng/mL, p < 0.02).
Conclusions: A short period of exercise training in CAD patients improved their physical
capacity, but did not influence BMI, WHR and waist circumference. Exercise training pre-
vented an increase in leptin levels during the study period. (Cardiol J 2010; 17, 5: 477–481)
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Introduction
Adipose tissue, as an active endocrine organ,
releases proteins termed adipokines, including a hor-
mone known as leptin. It has been established that
increased leptin levels are common in obese and dia-
betic patients and independently associated with in-
sulin resistance [1], cardiovascular diseases [2, 3], and
low-grade chronic inflammation in humans [4, 5].
To date, the influence of regular physical ac-
tivity on leptin levels has been examined in healthy
subjects as well as in obese and diabetic patients.
The effects of exercise training on leptin le-
vels in patients with coronary artery disease (CAD)
are unknown. Therefore, the aim of this pilot study
was to assess the influence of six- weeks of exer-
cise training on leptin levels in patients with stable
coronary artery disease.
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Methods
We enrolled consecutive male patients < 65 ye-
ars, with stable CAD, who had been referred for
our exercise training program between 1 January
and 31 December 2007. We excluded patients with
heart failure, unstable angina, diabetes mellitus, un-
controlled arrhythmias, poorly controlled hyperten-
sion, hemodynamically significant valvular heart
disease, those with chronic inflammatory, autoim-
mune, neoplastic, or other systemic diseases,
chronic hepatic or kidney diseases. All the patients
were clinically stable at least one month before their
inclusion in the program, without any changes in
medical treatment. The subjects received standard
medications such as statin, aspirin, beta-blocker and
angiotensin-converting enzyme inhibitor. The dos-
es of medications were not changed during the
study period. The study protocol was approved by
the Local Ethics Committee. Afterwards, a written
informed consent was obtained from each patient.
The patients were randomized into two groups:
training group (Ex) and control group. Ex patients
agreed to participate in our training program. The
baseline evaluation included clinical history and
examination, resting electrocardiogram, chest
X-ray, two-dimensional echocardiogram, blood
chemistry (total and high- and low-density lipopro-
tein cholesterol, triglycerides, fasting and post-
prandial glucose levels, and liver and kidney func-
tion tests), We defined patients as non-smokers
when they had not smoked tobacco for at least one
year. All the patients were advised to follow a diet
containing limited amounts of fat and high-carbo-
hydrate foods, and not to change the diet during the
study protocol.
Anthropometry
Fasting body weight and height were measured
(B 150 L, Axis, Poland) in all participants wearing
only underclothes, without shoes. Height was mea-
sured without shoes to within an accuracy of 1 cm.
Waist-to-hip ratio (WHR) was measured as a ratio
of the circumference of the waist [cm] to that of the
hips [cm]. Body mass index (BMI) was calculated
as [kg/m²].
Blood sampling and
laboratory measurements
All the participants were told to avoid vigor-
ous exercise for four days before blood sampling.
Blood samples were collected between 8 and 10am
after an overnight fast. EDTA was added to whole
blood for plasma preparation. The parameters of
blood chemistry e.g. glucose, lipids, etc. were mea-
sured in fresh plasma by standard methods. Plas-
ma samples for leptin measurement were immedi-
ately centrifuged (2,000 rpm for 10 min), decanted
and frozen at temperature –70°C. Leptin concentra-
tion in plasma samples was quantified using Human
Leptin RIA (RadioImmunoAssay) kit from Linco
Research, Inc., St. Charles, Missouri, USA. Sensi-
tivity of the assay was 0.5 ng/mL. Intra- and inter-
assay coefficients of variation were 4.6% and 6.2%,
respectively.
Exercise stress testing
Each subject performed a symptom-limited
maximal exercise treadmill test according to the
modified Bruce protocol. Blood pressure was moni-
tored by using mercurial sphygnomanometer and
a 12-lead ECG was recorded at rest, every minute
during exercise and during recovery, until heart rate
(HR) and ECG returned to the baseline values (us-
ing the modified Mason-Likar 12-lead system, Mar-
quette Case 12; Marquette Electronics, Milwaukee,
Wisconsin, USA). All treadmill tests were super-
vised by a cardiologist. The main reasons of stop-
ping the tests were reaching the age-adjusted limit
of HR and/or fatigue. None of the tests were dis-
continued because of signs of ischemia in ECG and/
/or angina. The following parameters were analyzed:
duration and distance of exercise stress test, work-
load in metabolic equivalents (METs), HR at rest
and at peak exercise (max HR).
Exercise training program
Ex group patients underwent a six-week con-
trolled, standardized exercise training program on
bicycle ergometer, three times a week. Each ses-
sion included a ten-minute warm-up, 40 minutes of
cycling with telemetry monitoring (the intensity set
at 60% at the beginning of the exercise program was
progressively increased to 80% of peak HR mea-
sured during exercise stress testing), and a ten-
minute cool-down. The training was documented by
a written protocol.
Cardiac rhythm was continuously monitored on
a three-channel telemetry system in all trained pa-
tients and in all sessions throughout the study. No
patient left the program at any point during the study.
Patients in the control group were advised to
walk at least three times per week for 30 minutes
during the study period.
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Statistical analysis
Statistical analysis was performed using SAS
statistical software (Version 9.2, Cary, North Caro-
lina, USA). Values are expressed as mean ± stan-
dard deviation for normally distributed variables.
Normal distribution was evaluated by the Shapiro-
-Wilk test. The difference in mean values was com-
pared with Student’s t-test, either the unpaired one
to detect differences between groups, or the paired
one to detect differences within each group over time.
Comparisons of non-normally distributed data
were carried out using the Wilcoxon rank test.
A p value of less than 0.05 was considered statisti-
cally significant.
Results
Baseline results
No significant differences were found between
Ex and control groups regarding age, number of
smokers, presence of hypertension, history of myo-
cardial infarction or left ventricular ejection fraction
(Table 1). There were no significant differences
between the groups in terms of baseline metabolic
parameters considered or BMI (Table 2). Similar-
ly, HR at rest and at peak exercise as well as METs
were comparable between the two groups at the
beginning of the study (Table 3). Moreover, at the
initial evaluation, leptin levels did not differ signif-
icantly between the two groups (Table 2).
Final results
Sixty-four patients completed the study. No
adverse events occurred in either group during the
study period. As shown in Table 2, no significant
differences were found between the two groups in
any of the analyzed metabolic parameters. More-
over, BMI, WHR and waist circumference were
stable and did not change significantly in either
study group during the study period. After six
weeks, exercise duration and distance improved
significantly in both study groups (Table 3). How-
ever, in the Ex group only, maximal workload in
METs increased significantly (7.7 ± 1.4 vs 8.2 ±
Table 1. Study population.
Characteristic Exercise Control P
group group
(n = 32) (n = 32)
Age (years) 54.0 ± 4.8 54.5 ± 5.6 NS
CAD (years) 3.9 ± 4.6 2.8 ± 3.7 NS
History MI 20 (62%) 19 (58%) NS
Non-smokers 28 (87%) 27 (83%) NS
Smokers 4 (13%) 5 (17%) NS
Hypertension 25 (78%) 25 (78%) NS
Coronary
angiography:
1 vessel 5 (16%) 5 (16%) NS
2 vessels 11 (34%) 7 (22%) NS
3 vessels 16 (50%) 20 (62%) NS
Medication:
Beta-blocker 32 (100%) 32 (100%) NS
ACE-I 30 (94%) 30 (94%) NS
AT II blocker 3 (9%) 2 (6%) NS
Statins 32 (100%) 32 (100%) NS
Aspirin 31 (98%) 31 (98%) NS
Clopidogrel/ 2 (6%) 2 (6%) NS
/ticlopidine
LVEF (%) 60.0 ± 7.5 56.8 ± 8.9 NS
CAD — coronary artery disease; MI — myocardial infarction; ACE-I
— angiotensin converting enzyme inhibitor; AT II blocker — angio-
tensin II receptor blocker; LVEF — left ventricular ejection fraction;
NS — non significant
Table 2. Metabolic parameters at baseline and at the end of the study.
Variables Exercise group (n = 32) Control group (n = 32)
Baseline Final Baseline Final
Body mass index [kg/m²] 27.3 ± 2.8 27.4 ± 2.8 28.0 ± 3.2 28.4 ± 3.6
Waist circumference [cm] 95.8 ± 7.0 96.0 ± 8.4 99.6 ± 7.6 99.8 ± 7.5
Waist-to-hip ratio 1.02 ± 0.05 1.01 ± 0.05 1.03 ± 0.05 1.03 ± 0.06
Total cholesterol [mmol/L] 3.9 ± 0.7 3.8 ± 0.8 4.1 ± 0.6 4.2 ± 1.0
HDL cholesterol [mmol/L] 1.3 ± 0.4 1.3 ± 0.5 1.3 ± 0.4 1.3 ± 0.3
LDL cholesterol [mmol/L] 2.4 ± 0.8 2.3 ± 0.7 2.6 ± 0.8 2.6 ± 0.7
Triglycerides [mmol/L] 1.3 ± 0.6 1.4 ± 0.7 1.4 ± 0.7 1.5 ± 0.9
Fasting glucose [mmol/L] 5.1 ± 0.7 5.1 ± 0.7 5.2 ± 0.7 5.2 ± 0.6
Post-prandial glucose [mmol/L] 5.5 ± 1.5 5.6 ± 1.6 5.7 ± 1.8 5.6 ± 1.5
Leptin [ng/mL] 6.7 ± 3.2 6.9 ± 3.6 8.0 ± 4.0 9.3 ± 5.2*
All results are presented as mean ± SD; *p < 0.05
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± 1.4, p < 0.03) compared to the control patients
(7.3 ± 1.8 vs 7.7 ± 1.9, p = NS; Table 3).
Although, at the end of the study, leptin levels
increased significantly only in the control patients
(15% vs 2% in Ex group), there were no signifi-
cant statistical differences between the two study
groups (Table 2).
Discussion
This preliminary study aimed to investigate the
effect of short-term exercise training on plasma
leptin concentrations in stable CAD patients with
preserved left ventricular function.
We found that our supervised exercise-train-
ing program improved physical capacity and did not
affect leptin levels. On the contrary, in control pa-
tients, home-based activity e.g. walking did not
change physical capacity measured in METs and
caused an unfavorable increase in leptin levels.
Leptin is secreted by adipose tissue and its
concentration in humans is known to correlate with
weight, BMI [6] and body fat mass [7–9]. Moreover,
leptin is thought to exert many potentially proat-
herogenic effects such as induction of endothelial
cell dysfunction [10] and platelet aggregation [11],
stimulation of inflammatory reactions [4, 5], propa-
gation of oxidative stress [12], and proliferation of
vascular smooth muscle cells [13].
To date, the influence of exercise training on
leptin levels has been examined only in healthy,
obese or diabetic patients. The majority of these
studies have documented that short-term exercise
training does not affect leptin levels.
However, Ishii et al. [14] showed that in type 2
diabetic patients, exercise training reduced plasma
leptin levels, which was independent of changes in
body fat mass.
Ours was the first study to show the influence
of short aerobic training on leptin levels in patients
with CAD. It should be emphasized that BMI,
WHR and waist circumference did not change sig-
nificantly in either of our study groups. Thus, we
can conclude that an increase in plasma leptin con-
centration in the control patients was not asso-
ciated with changes in weight or waist circumfe-
rence. Since a significant increase of physical ca-
pacity measured in METs was observed only in the
trained patients. We suggest that only a properly
applied training program is able to prevent an in-
crease in leptin level in optimally treated, clinically
stable CAD patients.
Our findings, although promising, require con-
firmation on a larger number of patients to deter-
mine whether exercise training has a beneficial
impact on leptin levels. In addition, the mechanism
of favorable influence of exercise training on leptin
levels deserves further investigation.
It might be of great importance, because se-
veral clinical studies have demonstrated that high
leptin levels predicted the development of acute
cardiovascular events, restenosis after coronary
angioplasty and cerebral stroke, independently of
traditional risk factors [2, 15, 16].
Limitations of the study
When interpreting our findings, one should
take into account that this was a small, short-du-
ration pilot study aimed only at determining
whether exercise training had any impact on lep-
tin levels. Our study did not assess the percent-
age of body fat. However, Flegal et al. [17] showed
that it positively correlated with waist circumfer-
ence in men, which was measured in our patients.
We did not include women in this study because
it is widely recognized that leptin levels are se-
veral times higher in women that in men, indepen-
dently of fat mass content, suggesting that fe-
males have higher leptin levels per unit fat mass
[18, 19].
Table 3. Parameters during exercise stress test at baseline and at the end of the study.
Variables Exercise group (n = 32) Control group (n = 32)
Baseline Final Baseline Final
Duration [s] 759.8 ± 96.8 830.1 ± 74.7* 750.5 ± 102.8 781.0 ± 136.5*
Distance [m] 672.7 ± 135.5 778.7 ± 117.8* 644.1 ± 152.3 717.6 ± 164.2*
Metabolic equivalents 7.7 ± 1.4 8.2 ± 1.4* 7.3 ± 1.8 7.7 ± 1.9
Heart rate at rest [bpm] 68.1 ± 11.3 62.9 ± 10.5* 65.1 ± 9.4 64.2 ± 8.2
Max heart rate [bpm] 125.9 ± 15.2 124.8 ± 15.6 121.2 ± 16.7 125.4 ± 15.3
All results are presented as mean ± SD; *p < 0.05
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Conclusions
1. A short period of exercise training in CAD pa-
tients improved physical capacity, but did not
influence BMI, WHR or waist circumference.
2. Exercise training prevented an increase in lep-
tin levels during the study period.
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